Skip to content

Nicole Amavisca

2 papers in the library · 2 citations · publishing 2022

Papers

Making the Case for Psychedelics: Comparing Alternative Treatment Options for Depression

January 1, 2022 Nicole Amavisca, Nicole Amavisca 1 citation

A review compares the antidepressant potential of the hallucinogens ketamine and psilocybin against traditional antidepressants like bupropion and SSRIs. Psilocybin mimics ketamine in showing promising results as a fast-acting antidepressant, especially when paired with psychotherapy. Unlike traditional antidepressants that take 4-6 weeks to take full effect and require daily ingestion, a single treatment of ketamine or psilocybin can provide rapid antidepressant effects. Current research suggests that ketamine and psilocybin are safe, effective, tolerable, and fast-acting treatments for depression, though more data are needed.

Making the Case for Psychedelics: Comparing Alternative Treatment Options for Depression

January 1, 2022 Nicole Amavisca, Nicole Amavisca 1 citation

A review compares the antidepressant potential of the hallucinogens ketamine and psilocybin against traditional antidepressants like bupropion and SSRIs. Psilocybin mimics ketamine in showing promising results as a fast-acting antidepressant, especially when paired with psychotherapy. Unlike traditional antidepressants that take 4-6 weeks to take full effect and require daily ingestion, a single treatment of ketamine or psilocybin can provide rapid antidepressant effects. Current research suggests that ketamine and psilocybin are safe, effective, tolerable, and fast-acting treatments for depression, though more data are needed.